St.Antonius Hospital

Nieuwegein 3435 CM

3 studies enrolling now · 23 studies all time

What they study most

Acute Pancreatitis, Angioplasty, Transluminal, Percutaneous Coronary, Aortic Aneurysm, Aortic Regurgitation, Aortic Valve Stenosis, Autoimmune Pulmonary Alveolar Proteinosis, Barrett's Esophagus, Breast Cancer, Cardiovascular Disease, Cardiovascular Diseases, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities, Coronary Artery Disease

Studies at this site

• An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL) — Recruiting now
• SELUTION4BTK Trial — Recruiting now
• PALbociclib CoLlaborative Adjuvant Study — Running, not enrolling
• Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia — Completed
• ANCHOR (Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System Global Registry) — Completed
• Assess Safety and Efficacy of VAD044 in HHT Patients — Running, not enrolling
• Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment — Running, not enrolling
• Conventional Endoscopic Techniques Versus EndoRotor® System for Necrosectomy of Walled of Necrosis — Enrolling by invitation
• Expanded Clinical Study of the Tendyne Mitral Valve System — Completed
• Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer — Completed
• Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure — Completed
• A PRospective, rAndomizEd Comparison of subcuTaneOous and tRansvenous ImplANtable Cardioverter Defibrillator Therapy — Status unconfirmed
• Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis — Completed
• JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study — Status unconfirmed
• THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study — Running, not enrolling
• Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Barrett's Epithelium — Completed
• Study of Zevalin Versus Observation in Participants at Least 60 Years Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in Positron Emission Tomography (PET)-Negative Complete Remission After Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) or R-CHOP-like Therapy — Stopped early
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Interventional Management of Stroke (IMS) III Trial — Stopped early
• SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries — Status unconfirmed
• The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention — Completed